Kailin Yang, Md, Phd

This early-phase trial tests whether sitagliptin, a diabetes medicine, can boost the immune system to fight recurrent grade 4 gliomas (a fast-growing brain cancer). About 45 adults whose cancer has returned after standard treatment will receive sitagliptin combined with bevacizum…